Pharma needs a new idea
One with a clear vision toward an easier, less expensive path for consumers. One that improves the patient experience while delivering value to manufacturers.
ENGINUITY Rx brings this vision to life
We’ve built a one-of-a-kind D2C patient acquisition engine for pharma brands, designed to significantly improve marketing insight via our closed-loop data system.
With an eCommerce approach, we can improve written to filled Rx rates through stronger reimbursement.
And with a focus on people, we can also create a delightful experience. One designed to reduce frictions. One that connects more people with important branded medications.
It’s really a win-win.
Our closed system—data makes all the difference
ENGINUITY Rx has developed a deeply integrated, closed ecosystem of digital healthcare, driven by a smarter, AI-powered engine. A platform that delivers first-party data at each step of the funnel. With this data, ENGINUITY Rx can:
- Uncover new insights to create better targeting, messaging, and conversion.
- Convert interest in your brand to payer-reimbursed customers.
- Retain customers longer, and more effectively reach lapsed users.
A turnkey acquisition & retention engine for branded medicine
We’re all well past the days of using a “Talk to a Doctor Now” button to drive conversion. Those results were disappointing. ENGINUITY Rx generates greater TRx from each patient request versus the traditional pharma-promotion path.
We fund acquisition costs—earning our compensation based on prescriptions generated through our channels.
Bottom line: you have no costs if we’re not successful.
Meet the leadership team
ENGINUITY Rx gives you a single point of accountability for your media spend and NRx results.
Chairman/CEO
Peter Miller
Peter is a seasoned healthcare leader with 30+ years’ experience driving growth through innovation. He has led a multi-billion-dollar pharma company at Johnson & Johnson, co-founded a retail health clinic model that scaled to 350 locations, and served as CEO of a biotech company. Peter brings his deep expertise in patient experience, demand generation, and reimbursement strategy to ENGINUITY Rx.
President/COO
Lance Tyler
Lance is a go-to-market strategist and commercial organization builder with experience in pharma and biotech startups. At Boehringer Ingelheim, Lance drove digital modernization and data-driven customer engagement. He later pioneered a digital-first, telehealth-forward launch of Plenity at Gelesis. Lance now applies his expertise to develop ENGINUITY Rx’s capabilities in support of partner brands.
This is too valuable—and important—to keep secret
ENGINUITY Rx is a technology company; a collective of partners doing what they do best within a closed system of care.
- Smarter marketing for pharma
- A better experience for patients
- Available now—not years from now